COVID-19 Records

URGENT review by 8am Wed. 7/17: HHS Comments to OMB on Risky Research Review Act

Reading Room Production, pp.112-113 · reading_room:email:00116

Page text: p.112, p.113 · original PDF

Date
2024-07-16 18:07
Type
email · email
cc
Emily Erbelding, Steven Holland, Christopher Hanson, Kelly Poe, Sharon Gilles, Ddsm Correspondences
sender
Sara Selgrade
to
Robert Eiss, Michael Nealy, Hugh Auchincloss, Jill Harper, Marie Parker, Courtney Billet

This text appears inside a quoted reply chain — it is evidence that the message was circulating, not necessarily a new message.

This is a duplicate copy. Canonical version: reading_room:email:00124

Hello all, ] ool DMID has suggested comments in 2ase of review. Please let me know if you have any questions. i 4PM AID DEA DART NIAID) [E] NIAID) [E] VIH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] ents on the bill HHS is asking In particular, we have flagged a Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

  1. 2024-07-16 18:07 Sara Selgrade
    Hello all, ] ool DMID has suggested comments in 2ase of review. Please let me know if you have any questions. i 4PM AID DEA DART NIAID) [E] NIAID) [E] VIH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] ents on the bill HHS is asking In particular, we have flagged a Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment
  2. 2024-07-16 18:07 Sara Selgrade open
    Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment ol I ol CL 4PM AID DEA DART NIAID) [E] 7 NIAID) [E] \IH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] ents on the bill HHS is asking In particular, we have flagged a OLPA plans to include the specific sked to review consolidated NIH Please let me know if you have any questions. i 6 PM [AID DEA DART NIAID) [2] i I NIAID) [E] VIH/NIAID) [E] i NIH/NIAID) [E] J VIH/NIAID) [I] >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E]
  3. 2024-07-16 18:07 Sara Selgrade open
    Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment
  4. 2024-07-16 18:07 Sara Selgrade open
    Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment
  5. 2024-07-16 18:07 Sara Selgrade open
    Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions. ol CL 4PM [AID DEA DART NIAID) [E] i I NIAID) [E] VIH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] ndences ay > ents on the bill HHS is asking In particular, we have flagged a OLPA plans to include the specific sked to review consolidated NIH Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment

Full conversation →